Skip to content

Safety and Feasibility of tDCS to Enhance Auditory Rehabilitation in Cochlear Implant Recipients

Safety and Feasibility of Transcranial Direct Current Stimulation to Enhance Auditory Rehabilitation in Cochlear Implant Recipients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04908631
Enrollment
8
Registered
2021-06-01
Start date
2023-03-15
Completion date
2024-07-29
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Keywords

Cochlear Implant

Brief summary

This study aims to evaluate the safety and feasibility of transcranial direct current stimulation (tDCS) in combination with home-based auditory training therapy in cochlear implant (CI) patients. Changes in speech perception performance will also be evaluated.

Detailed description

Participants will complete a 4 week web-based auditory training program while wearing a transcranial direct current stimulation device (tDCS). The customized auditory training program will be completed at home, in 20 - 30 minute sessions at least five times a week for four weeks. A customized learning and practice plan will be provided along with instructions on use of the tDCS device. tDCS is a non-invasive brain stimulation technique that delivers low-intensity current via electrodes on the scalp to modify neuronal excitability in the underlying cortex. The tDCS system has customizable headgear with disposable, snap-in electrodes that are easy to apply at home without assistance. Speech and hearing assessments will be completed prior to the start of auditory training, at the end of the 4 week training session, and again 6 months later.

Interventions

Brain stimulation using low-intensity current via electrodes on scalp to modify neuronal excitability in the underlying cortex. The tDCS system has customizable head gear with disposable, snap-in electrodes wihich can be applied at home without assistance.

Web-based program uses consonant and vowel recognition and understanding sentences/conversations in quiet and in noise using different talkers, and other types of listening exercises.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>/= 18 years of age * Patients with a Unilateral Cochlear Implant device in use for a minimum of 1 year * Sentence recognition scores (AzBio) below 65% and/or word recognition scores (CNC) are below 75% in the implanted ear for \> one year following cochlear implantation. * Ability to access internet to conduct computer-based auditory trainings and weekly video visits with study team weeks 2-5

Exclusion criteria

* Non-English speaking * Diagnosis (documented or self-reported) of a psychiatric or neurologic condition, or any other comorbidities that may interfere with the study or increase the level of risk (such as dementia, seizures, legal blindness, brain tumor) * Implants, other than CI, above collar bone level that may interact with delivery of tDCS * Inability to or unwillingness to use electronic devices/computers, participate in video visits, or make required visits

Design outcomes

Primary

MeasureTime frameDescription
Cochlear Implant Quality of Life-35 Profile (CIQOL35) QuestionnaireBaseline, 1 month, 6 monthsThe CIQOL35 raw score is calculated by summing the items for each domain. In this case, the raw score for the Global 10 domain is reported. The range in raw scores is 10-50, where a higher score indicates great quality of life.
Number of Participants Who Experienced Skin Irritation From Use of tDCS6 monthsMeasured by provider visual exam of scalp. Skin tingling/warmth is a known side effect of stimulation.
Number of Subjects Who Experienced Abnormal Function of Cochlear Implant Device6 monthsMeasured by telemetry assessment.
Speech Perception Performance - Sentence Recognition in QuietBaseline, 1 month, 6 monthMeasured by word and sentence lists presented in quiet (AzBio Quiet). Average of two AzBio lists presented in quiet. Range of scores is from 0-100, with higher scores indicating higher speech perception performance.
Speech Perception Performance - Word Recognition PerformanceBaseline, 1 month, 6 monthMeasured by 50-item CNC word list. CNC word lists are standardized sets of monosyllabic words used in audiology to assess speech recognition ability, particularly in cochlear implant users. Reported as a percentage (0-100%), with higher values indicating better word recognition.
Communication Function as Measured by Speech, Spatial and Qualities of Hearing (SSQ12) QuestionnaireBaseline, 1 month, 6 monthsThe SSQ12 questionnaire is scored as a mean of the 12 items, with a range of 0 to 10. A higher score indicates greater communication function.
Number Eligible Patients Who Expressed Interest in the StudyDuring the screening period of approximately 6 months
Number of Subjects Who Completed tDCS Trainingup to 7 monthsMeasured by total number of subjects enrolled who completed tDCS during auditory training
Number of Participants Who Demonstrated Competence of tDCS Training1 monthMeasured by provider observation during in-office and tele-visits
Number of Participants Who Reported Ease of Completing the Training Program1 monthNumber of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.
Number of Participants Who Reported an Adverse Event30 daysMeasured by daily diary survey completion.

Secondary

MeasureTime frameDescription
Number of Participants Who Reported Use of the Stimulation Device to be Acceptable1 monthNumber of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.
Number of Participants Who Reported Improvement in Hearing Performance1 monthNumber of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.
Number of Participants Who Would Recommend the Training Program1 monthNumber of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.
Number of Participants Who Reported Acceptable Compensation for Study Participation1 monthNumber of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.
Number of Participants Who Enjoyed Doing the Listening Exercises on the Computer1 monthNumber of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Countries

United States

Participant flow

Participants by arm

ArmCount
tDCS During Auditory Training
Use of tDCS during completion of the auditory training program Transcranial Direct Stimulation: Brain stimulation using low-intensity current via electrodes on scalp to modify neuronal excitability in the underlying cortex. The tDCS system has customizable head gear with disposable, snap-in electrodes wihich can be applied at home without assistance. Auditory Training Program: Web-based program uses consonant and vowel recognition and understanding sentences/conversations in quiet and in noise using different talkers, and other types of listening exercises.
8
Total8

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1
Overall StudyPhysician Decision1
Overall StudyReceived a second implant after the 1 month visit1

Baseline characteristics

CharacteristictDCS During Auditory Training
Age, Continuous63.9 years
STANDARD_DEVIATION 15.6
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
5 Participants
Region of Enrollment
United States
8 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 7
other
Total, other adverse events
0 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Cochlear Implant Quality of Life-35 Profile (CIQOL35) Questionnaire

The CIQOL35 raw score is calculated by summing the items for each domain. In this case, the raw score for the Global 10 domain is reported. The range in raw scores is 10-50, where a higher score indicates great quality of life.

Time frame: Baseline, 1 month, 6 months

Population: One participant withdrew prior to 1 month; one additional participant withdrew prior to 6 months.

ArmMeasureGroupValue (MEAN)Dispersion
tDCS During Auditory TrainingCochlear Implant Quality of Life-35 Profile (CIQOL35) Questionnaire6 months36.8 score on a scaleStandard Deviation 5.4
tDCS During Auditory TrainingCochlear Implant Quality of Life-35 Profile (CIQOL35) QuestionnaireBaseline32.9 score on a scaleStandard Deviation 4.7
tDCS During Auditory TrainingCochlear Implant Quality of Life-35 Profile (CIQOL35) Questionnaire1 month36.0 score on a scaleStandard Deviation 6.1
Primary

Communication Function as Measured by Speech, Spatial and Qualities of Hearing (SSQ12) Questionnaire

The SSQ12 questionnaire is scored as a mean of the 12 items, with a range of 0 to 10. A higher score indicates greater communication function.

Time frame: Baseline, 1 month, 6 months

Population: One participant withdrew prior to 1 month; one additional participant withdrew prior to 6 months.

ArmMeasureGroupValue (MEAN)Dispersion
tDCS During Auditory TrainingCommunication Function as Measured by Speech, Spatial and Qualities of Hearing (SSQ12) QuestionnaireBaseline3.6 score on a scaleStandard Deviation 1.9
tDCS During Auditory TrainingCommunication Function as Measured by Speech, Spatial and Qualities of Hearing (SSQ12) Questionnaire1 month4.5 score on a scaleStandard Deviation 1.6
tDCS During Auditory TrainingCommunication Function as Measured by Speech, Spatial and Qualities of Hearing (SSQ12) Questionnaire6 months4.5 score on a scaleStandard Deviation 2.1
Primary

Number Eligible Patients Who Expressed Interest in the Study

Time frame: During the screening period of approximately 6 months

Population: Eligible patients who expressed interest in the study.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber Eligible Patients Who Expressed Interest in the Study61 Participants
Primary

Number of Participants Who Demonstrated Competence of tDCS Training

Measured by provider observation during in-office and tele-visits

Time frame: 1 month

Population: One participant withdrew before the baseline visit.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Demonstrated Competence of tDCS Training7 Participants
Primary

Number of Participants Who Experienced Skin Irritation From Use of tDCS

Measured by provider visual exam of scalp. Skin tingling/warmth is a known side effect of stimulation.

Time frame: 6 months

Population: One participant withdrew before the baseline visit.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Experienced Skin Irritation From Use of tDCS6 Participants
Primary

Number of Participants Who Reported an Adverse Event

Measured by daily diary survey completion.

Time frame: 30 days

Population: One participant withdrew before the baseline visit. One participant did not complete the daily diary.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Reported an Adverse Event0 Participants
Primary

Number of Participants Who Reported Ease of Completing the Training Program

Number of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Time frame: 1 month

Population: One participant withdrew before the baseline visit. One participant did not complete the training.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Reported Ease of Completing the Training Program6 Participants
Primary

Number of Subjects Who Completed tDCS Training

Measured by total number of subjects enrolled who completed tDCS during auditory training

Time frame: up to 7 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Subjects Who Completed tDCS Training6 Participants
Primary

Number of Subjects Who Experienced Abnormal Function of Cochlear Implant Device

Measured by telemetry assessment.

Time frame: 6 months

Population: One participant withdrew prior to the baseline visit.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Subjects Who Experienced Abnormal Function of Cochlear Implant Device0 Participants
Primary

Speech Perception Performance - Sentence Recognition in Quiet

Measured by word and sentence lists presented in quiet (AzBio Quiet). Average of two AzBio lists presented in quiet. Range of scores is from 0-100, with higher scores indicating higher speech perception performance.

Time frame: Baseline, 1 month, 6 month

Population: Seven participants had a baseline assessment. One withdrew prior to 1 month; one additional participant withdrew prior to 6 months.

ArmMeasureGroupValue (MEAN)Dispersion
tDCS During Auditory TrainingSpeech Perception Performance - Sentence Recognition in QuietBaseline59.6 score on a scaleStandard Deviation 33.1
tDCS During Auditory TrainingSpeech Perception Performance - Sentence Recognition in Quiet1 Month68.8 score on a scaleStandard Deviation 23.1
tDCS During Auditory TrainingSpeech Perception Performance - Sentence Recognition in Quiet6 Months67.4 score on a scaleStandard Deviation 25.4
Primary

Speech Perception Performance - Word Recognition Performance

Measured by 50-item CNC word list. CNC word lists are standardized sets of monosyllabic words used in audiology to assess speech recognition ability, particularly in cochlear implant users. Reported as a percentage (0-100%), with higher values indicating better word recognition.

Time frame: Baseline, 1 month, 6 month

Population: Seven participants had a baseline assessment. One withdrew prior to 1 month; one additional participant withdrew prior to 6 months.

ArmMeasureGroupValue (MEAN)Dispersion
tDCS During Auditory TrainingSpeech Perception Performance - Word Recognition PerformanceBaseline43.1 percentage of wordsStandard Deviation 22.1
tDCS During Auditory TrainingSpeech Perception Performance - Word Recognition Performance1 Month55.3 percentage of wordsStandard Deviation 21.9
tDCS During Auditory TrainingSpeech Perception Performance - Word Recognition Performance6 Months47.2 percentage of wordsStandard Deviation 10.3
Secondary

Number of Participants Who Enjoyed Doing the Listening Exercises on the Computer

Number of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Time frame: 1 month

Population: One participant withdrew before the baseline visit. One participant did not complete the training.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Enjoyed Doing the Listening Exercises on the Computer6 Participants
Secondary

Number of Participants Who Reported Acceptable Compensation for Study Participation

Number of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Time frame: 1 month

Population: One participant withdrew before the baseline visit. One participant did not complete the training.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Reported Acceptable Compensation for Study Participation6 Participants
Secondary

Number of Participants Who Reported Improvement in Hearing Performance

Number of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Time frame: 1 month

Population: One participant withdrew before the baseline visit. One participant did not complete the training.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Reported Improvement in Hearing Performance5 Participants
Secondary

Number of Participants Who Reported Use of the Stimulation Device to be Acceptable

Number of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Time frame: 1 month

Population: One participant withdrew before the baseline visit. One participant did not complete the training.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Reported Use of the Stimulation Device to be Acceptable4 Participants
Secondary

Number of Participants Who Would Recommend the Training Program

Number of participants who reported agree or strongly agree as measured by questionnaire, where 1 equals strongly disagree and 5 equals strongly agree.

Time frame: 1 month

Population: One participant withdrew before the baseline visit. One participant did not complete the training.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
tDCS During Auditory TrainingNumber of Participants Who Would Recommend the Training Program4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026